A Single-center, Investigator-masked, Randomized, Placebo-controlled, Investigator-initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation.

Status: Completed
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \- Active blepharitis with collarettes

Locations
United States
California
Eye Research Foundation, Inc.
Newport Beach
Time Frame
Start Date: 2025-02-02
Completion Date: 2025-06-15
Participants
Target number of participants: 24
Treatments
Active_comparator: Active
Experimental: Active and Placebo
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: Eye Research Foundation, Inc.

This content was sourced from clinicaltrials.gov